Identifying, building and investing in exceptional startups

What we do

We identify, build and invest in innovative Nordic startup companies founded on strong science, with the ultimate goal of developing products that can transform patient treatment.

From startup to exit

Collaborating with outstanding researchers, academic institutions, entrepreneurs and leaders in the biotech and pharma industry, we provide capital, network and know-how to transform promising life-science discoveries into successful biotech startups.

We focus on company creation and building biotech startups in the Nordic region. We aim to develop strong and competitive companies that we finance all the way to a commercial exit.

In 2020, we made eight investments in new companies, and we currently have 32 portfolio companies. In the coming years, we will continue to increase our investments activities in the Nordics.




Through our hands-on approach, we ensure that promising projects and startup companies have the optimal conditions for success.

Søren Møller, Managing Partner, Novo Seeds
  • 32

    current portfolio companies.

  • 2000+

    projects and companies reviewed since 2007.

  • 5

    exits since 2007.

All teams

Meet our team

Novo Seeds is comprised of a team of passionate investment professionals, dedicated to working with scientists and entrepreneurs to build biotech companies in the Nordics.

See our team

Our headquarters

The Novo Seeds team is based at our headquarters in Copenhagen, Denmark.

Novo Holdings A/S
Tuborg Havnevej 19
2900 Hellerup
+45 3527 6500
CVR# 24257630